Search

Your search keyword '"Massie, Barry M."' showing total 289 results

Search Constraints

Start Over You searched for: Author "Massie, Barry M." Remove constraint Author: "Massie, Barry M." Database Unpaywall Remove constraint Database: Unpaywall
289 results on '"Massie, Barry M."'

Search Results

2. Contributors

6. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

7. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study

8. Patient journey after admission for acute heart failure: length of stay, 30‐day readmission and 90‐day mortality

9. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

10. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

13. Worsening Heart Failure Following Admission for Acute Heart Failure

14. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function

15. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial

19. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial

20. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

21. Depression and Outcome among Veterans with Implantable Cardioverter Defibrillators with or without Cardiac Resynchronization Therapy Capability

22. Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure

23. Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure

24. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND‐HF Trial

25. Sex‐specific acute heart failure phenotypes and outcomes from PROTECT

27. Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm

28. Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF

29. Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?

31. Clinical Pharmacy Services in Heart Failure: An Opinion Paper From the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network

32. Abstract 273: Incidence and Predictors of Heart Failure Hospitalization in Veterans Undergoing Cardioverter-Defibrillator Implantation in the Outcomes among Veterans with Implantable Defibrillators (OVID) Registry

34. Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network

36. The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure

37. Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

38. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF

41. Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study

42. CTST-21: A Phase 2, Randomized, Double-Blind, Multi-Center Study Comparing 15G Cross-Linked Polyelectrolyte (CLP) versus Placebo in Heart Failure Patients with Chronic Kidney Disease

43. Anticoagulation in heart failure: current status and future direction

44. Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction

45. A double‐blind, randomized, parallel, placebo‐controlled study examining the effect of cross‐linked polyelectrolyte in heart failure patients with chronic kidney disease

46. Response to Letters Regarding Article, “Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction”

47. The PROTECT in‐hospital risk model: 7‐day outcome in patients hospitalized with acute heart failure and renal dysfunction

48. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

50. The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

Catalog

Books, media, physical & digital resources